Iowa House lawmakers advanced a bill Tuesday aimed at reducing prescription drug costs for Iowans by strengthening some requirements for pharmacy benefit managers.
116 3rd St SE
Cedar Rapids, Iowa 52401
Articles Tagged: Prescription drug pricing
Pharmacies across Iowa have closed at an alarming rate over the past decade-plus, partly because insurance payouts don't cover drug costs. Iowa Republican U.S. Rep. Mariannette Miller-Meeks and colleagues this week introduced a proposal that would tackle practices used by pharmacy benefit managers that drive up costs for prescription medications.
That administration published state-level data after announcing 10 prescription drugs whose costs it plans to negotiate for Medicare patients under a new federal law
The popular diabetes treatment Jardiance and the blood thinner Eliquis are among the first drugs that will be targeted for price negotiations in effort to cut Medicare costs.
U.S. Sens. Chuck Grassley, R-Iowa, and Amy Klobuchar, D-Minnesota, say they have new confidence Congress will continue efforts to lower prescription drug costs.
A state lawmaker, children’s advocate, wife and mother, Democrat Liz Mathis said she has a track record of putting Iowans first and working across the aisle.
Cedar Rapids panelists discuss impact of Inflation Reduction Act
Insulin has become the poster-child drug when it comes to the debate over controlling skyrocketing drug prices and life-or-death stakes.
Democratic U.S. Senate candidate Mike Franken took Iowa Republican U.S. Sen. Chuck Grassley to task over efforts to lower prescription drug prices for Iowans.
The law addresses pharmacy benefits managers, which are middle men between pharmacies and insurance companies.
Measures include pharmacy benefits managers, child care costs
Public opinion polls have consistently shown support across party lines for capping the monthly cost of insulin. However, experts say the House bill would not help uninsured people, who face the highest out-of-pocket costs for insulin.
The Iowa Republican, who a year ago saw opportunities to work with his former Senate colleague on issues such as prescription drug pricing, now believes the president’s compromises to appease progressives are limiting his ability to reach bipartisan agreement on his proposals.
In a TV ad airing in Cedar Rapids and across the U.S., a pharmaceutical trade organization claims that proposed legislation to allow the federal government to negotiate with pharmaceutical companies on the cost of drugs would mean Medicare patients won’t be able to access the medications they need. But is that true?
Daily Newsletters